Dr. Marvin J. Slepian and James Wyant join those who have impacted quality of life, economic development and the welfare of society.Continue reading
Category Archives: AZBio News
Scottsdale Cure Corridor Event Focuses on Innovation and Access to Capital
On December 4, 2015, the City of Scottsdale hosted the third annual Cure Corridor luncheon with a a focus on the life saving and life changing innovations being discovered, developed and delivered across the Scottsdale Cure Corridor and featured a keynote from NEHI’s Jonathan Fleming.Continue reading
AZBio Trailblazers Conversations Focus on Investing in Arizona
Making LIFE Better by Investing in Arizona was the theme of the 2015 AZBio Trailblazer Awards and legislative luncheon. Continue reading
Congress Suspends The Medical Device Tax for Two Years
Medical device innovators got good news on December 18th as Congress passed a two-year moratorium on a tax the industry said was limiting its growth. Companies and industry backers in Arizona and around the country have worked for years to repeal the 2.3 percent tax on revenue from medical device sales. Continue reading
Phoenix Children’s Hospital Earns Coveted Top Rating from the Society of Thoracic Surgeons
Arizona’s only “Best Children’s Hospital” is one of just six three-star programs nationwideContinue reading
ASU expert discusses common stomach bug that is in the news once again
Norovirus, the gastrointestinal sickness that causes severe discomfort, has stricken 200 people at a Seattle holiday party and is suspected in the illnesses of 80 in Boston, according to news reports.Continue reading
Going Global? New Resources from the U.S. Commercial Service can help.
The 2016 Health Technologies Resource Report is now LIVE and filled with country by country data and analysis that can help you grow your business. This market intelligence is a FREE resource if the U.S. Commercial Service.
NuvOx Pharma receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational radiosensitizer for glioblastoma multiforme.Continue reading